Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Synthesis and imaging validation of [¹⁸F]MDL100907 enabled by Ni-mediated fluorination.

Ren H, Wey HY, Strebl M, Neelamegam R, Ritter T, Hooker JM.

ACS Chem Neurosci. 2014 Jul 16;5(7):611-5. doi: 10.1021/cn500078e.

2.

Extended characterisation of the serotonin 2A (5-HT2A) receptor-selective PET radiotracer 11C-MDL100907 in humans: quantitative analysis, test-retest reproducibility, and vulnerability to endogenous 5-HT tone.

Talbot PS, Slifstein M, Hwang DR, Huang Y, Scher E, Abi-Dargham A, Laruelle M.

Neuroimage. 2012 Jan 2;59(1):271-85. doi: 10.1016/j.neuroimage.2011.07.001.

3.

Total synthesis and evaluation of [18F]MHMZ.

Herth MM, Debus F, Piel M, Palner M, Knudsen GM, Lüddens H, Rösch F.

Bioorg Med Chem Lett. 2008 Feb 15;18(4):1515-9. doi: 10.1016/j.bmcl.2007.12.054.

PMID:
18187324
4.

Application of palladium-mediated (18)F-fluorination to PET radiotracer development: overcoming hurdles to translation.

Kamlet AS, Neumann CN, Lee E, Carlin SM, Moseley CK, Stephenson N, Hooker JM, Ritter T.

PLoS One. 2013;8(3):e59187. doi: 10.1371/journal.pone.0059187.

5.

Direct comparison of [(18) F]MH.MZ and [(18) F] altanserin for 5-HT2A receptor imaging with PET.

Hansen HD, Ettrup A, Herth MM, Dyssegaard A, Ratner C, Gillings N, Knudsen GM.

Synapse. 2013 Jun;67(6):328-37. doi: 10.1002/syn.21643.

PMID:
23390031
6.

Binding characteristics of the 5-HT2A receptor antagonists altanserin and MDL 100907.

Kristiansen H, Elfving B, Plenge P, Pinborg LH, Gillings N, Knudsen GM.

Synapse. 2005 Dec 15;58(4):249-57.

PMID:
16206185
7.

Current status of positron emission tomography radiotracers for serotonin receptors in humans.

Zimmer L, Le Bars D.

J Labelled Comp Radiopharm. 2013 Mar-Apr;56(3-4):105-13. doi: 10.1002/jlcr.3001. Review.

PMID:
24285316
8.

Synthesis and biological evaluation of positron emission tomography radiotracers targeting serotonin 4 receptors in brain: [18F]MNI-698 and [18F]MNI-699.

Caillé F, Morley TJ, Tavares AA, Papin C, Twardy NM, Alagille D, Lee HS, Baldwin RM, Seibyl JP, Barret O, Tamagnan GD.

Bioorg Med Chem Lett. 2013 Dec 1;23(23):6243-7. doi: 10.1016/j.bmcl.2013.09.097.

PMID:
24157369
9.

Synthesis, radiofluorination and first evaluation of [18F]fluorophenylsulfonyl- and [18F]fluorophenylsulfinyl-piperidines as serotonin 5-HT2A receptor antagonists for PET.

Mühlhausen U, Sihver W, Ermert J, Coenen HH.

Nucl Med Biol. 2010 Jul;37(5):605-14. doi: 10.1016/j.nucmedbio.2010.03.003.

PMID:
20610165
10.

Time-efficient and convenient synthesis of [(18)F]altanserin for human PET imaging by a new work-up procedure.

Massarweh G, Kovacevic M, Rosa-Neto P, Evans AC, Diksic M, Schirrmacher R.

Appl Radiat Isot. 2009 Nov;67(11):2040-3. doi: 10.1016/j.apradiso.2009.07.020.

PMID:
19692252
11.

High affinity radiopharmaceuticals based upon lansoprazole for PET imaging of aggregated tau in Alzheimer's disease and progressive supranuclear palsy: synthesis, preclinical evaluation, and lead selection.

Fawaz MV, Brooks AF, Rodnick ME, Carpenter GM, Shao X, Desmond TJ, Sherman P, Quesada CA, Hockley BG, Kilbourn MR, Albin RL, Frey KA, Scott PJ.

ACS Chem Neurosci. 2014 Aug 20;5(8):718-30. doi: 10.1021/cn500103u.

12.

Sustained recreational use of ecstasy is associated with altered pre and postsynaptic markers of serotonin transmission in neocortical areas: a PET study with [¹¹C]DASB and [¹¹C]MDL 100907.

Urban NB, Girgis RR, Talbot PS, Kegeles LS, Xu X, Frankle WG, Hart CL, Slifstein M, Abi-Dargham A, Laruelle M.

Neuropsychopharmacology. 2012 May;37(6):1465-73. doi: 10.1038/npp.2011.332.

13.

Synthesis and in vivo evaluation of novel PET radioligands for imaging the endothelin-A receptor.

Mathews WB, Murugesan N, Xia J, Scheffel U, Hilton J, Ravert HT, Dannals RF, Szabo Z.

J Nucl Med. 2008 Sep;49(9):1529-36. doi: 10.2967/jnumed.108.051565.

14.

Evaluation of [¹⁸F]MK-0911, a positron emission tomography (PET) tracer for opioid receptor-like 1 (ORL1), in rhesus monkey and human.

Hostetler ED, Sanabria-Bohórquez S, Eng W, Joshi AD, Patel S, Gibson RE, O'Malley S, Krause SM, Ryan C, Riffel K, Bi S, Okamoto O, Kawamoto H, Ozaki S, Ohta H, de Groot T, Bormans G, Depré M, de Hoon J, De Lepeleire I, Reynders T, Cook JJ, Burns HD, Egan M, Cho W, van Laere K, Hargreaves RJ.

Neuroimage. 2013 Mar;68:1-10. doi: 10.1016/j.neuroimage.2012.11.053.

PMID:
23238431
15.

Synthesis and in vivo evaluation of [O-methyl-11C](2R,4R)-4-hydroxy-2-[2-[2-[2-(3-methoxy)phenyl]ethyl]phenoxy]ethyl-1-methylpyrrolidine as a 5-HT2A receptor PET ligand.

Kumar JS, Prabhakaran J, Erlandsson K, Majo VJ, Simpson NR, Pratap M, Van Heertum RL, Mann JJ, Parsey RV.

Nucl Med Biol. 2006 May;33(4):565-74.

PMID:
16720250
16.

Characterization of [(11)C]Cimbi-36 as an agonist PET radioligand for the 5-HT(2A) and 5-HT(2C) receptors in the nonhuman primate brain.

Finnema SJ, Stepanov V, Ettrup A, Nakao R, Amini N, Svedberg M, Lehmann C, Hansen M, Knudsen GM, Halldin C.

Neuroimage. 2014 Jan 1;84:342-53. doi: 10.1016/j.neuroimage.2013.08.035.

PMID:
23994452
17.

Synthesis and characterization of two PET radioligands for the metabotropic glutamate 1 (mGlu1) receptor.

Huang Y, Narendran R, Bischoff F, Guo N, Bae SA, Hwang DR, Lesage AS, Laruelle M.

Synapse. 2012 Dec;66(12):1002-14. doi: 10.1002/syn.21606. Erratum in: Synapse. 2013 Feb;67(2):109.

PMID:
22927303
18.

Synthesis and in vitro affinities of various MDL 100907 derivatives as potential 18F-radioligands for 5-HT2A receptor imaging with PET.

Herth MM, Kramer V, Piel M, Palner M, Riss PJ, Knudsen GM, Rösch F.

Bioorg Med Chem. 2009 Apr 15;17(8):2989-3002. doi: 10.1016/j.bmc.2009.03.021.

PMID:
19329329
19.

Pre- and postsynaptic serotonergic differences in males with extreme levels of impulsive aggression without callous unemotional traits: a positron emission tomography study using (11)C-DASB and (11)C-MDL100907.

Rylands AJ, Hinz R, Jones M, Holmes SE, Feldmann M, Brown G, McMahon AW, Talbot PS.

Biol Psychiatry. 2012 Dec 15;72(12):1004-11. doi: 10.1016/j.biopsych.2012.06.024.

PMID:
22835812
20.

A fluoride-derived electrophilic late-stage fluorination reagent for PET imaging.

Lee E, Kamlet AS, Powers DC, Neumann CN, Boursalian GB, Furuya T, Choi DC, Hooker JM, Ritter T.

Science. 2011 Nov 4;334(6056):639-42. doi: 10.1126/science.1212625.

Items per page

Supplemental Content

Support Center